# HLF

## Overview
The HLF gene encodes the Hepatic Leukemia Factor, a transcription factor that is part of the PAR bZIP family, characterized by its basic leucine zipper (bZIP) domain. This domain is crucial for the protein's ability to bind DNA and form dimers, which are essential for its function as a transcriptional regulator. The HLF transcription factor plays a significant role in cellular responses to hypoxia by activating gene expression through hypoxia response elements (Ema1999Molecular). It is involved in various physiological processes, including metabolic homeostasis and cell survival under low oxygen conditions (Ema1999Molecular). Clinically, HLF is implicated in several diseases, including cancer and epilepsy, where its expression levels and functional alterations can influence disease progression and outcomes (Lin2024Pancancer; Rambousek2020Aberrant). The gene's involvement in these conditions highlights its potential as a therapeutic target and its importance in maintaining normal cellular functions.

## Structure
The HLF (Hepatic Leukemia Factor) protein is a member of the PAR bZIP family of transcription factors, characterized by a basic leucine zipper (bZIP) domain. This domain is essential for DNA binding and protein dimerization, allowing HLF to bind to specific DNA sequences such as the consensus site 5'-GTTACGTAAT-3' (Hunger1996The). The bZIP domain includes a basic region responsible for DNA binding and an adjacent amphipathic alpha-helical domain known as the leucine zipper, which mediates dimerization (Hunger1994DNABinding).

The primary structure of HLF includes a predicted open reading frame of 885 nucleotides, encoding a protein of 295 amino acids (Hunger1992Hlf). The secondary structure likely involves the formation of alpha-helices in the bZIP region, facilitating DNA binding and dimerization (Hunger1992Hlf). The transcriptional activation domain (TAD) of HLF is located within a 40 amino acid region, which is predicted to have a helical secondary structure (Hunger1996The).

HLF can function as a homodimer or form heterodimers with other PAR proteins, such as TEF and DBP, which is crucial for its transcriptional regulatory properties (Hunger1992Hlf). The E2A-HLF fusion protein, resulting from a chromosomal translocation in leukemia, exhibits altered DNA-binding properties and can form heterodimers with other bZIP proteins (Hunger1992Hlf).

## Function
HLF (Hepatic Leukemia Factor) is a transcription factor that plays a significant role in the cellular response to hypoxia, a condition characterized by low oxygen levels. In healthy human cells, HLF functions as an inducible transcription factor, particularly in association with the aryl hydrocarbon receptor nuclear translocator (Arnt) under hypoxic conditions. It activates gene expression by binding to specific DNA sequences known as hypoxia response elements (HREs) (Ema1999Molecular).

HLF contains two transcriptional activation domains: the N-terminal activation domain (NAD) and the C-terminal activation domain (CAD). These domains are crucial for its role in hypoxia-inducible transcriptional activation. The CAD domain interacts with the CREB-binding protein (CBP)/p300, a co-activator of transcription, through a mechanism involving thiol-redox regulators like Ref-1 and thioredoxin. This interaction is essential for the transcriptional activation of target genes under hypoxic conditions (Ema1999Molecular).

The stabilization of HLF under hypoxia is facilitated by the NAD sequence, while the CAD domain's activity is regulated by redox signaling pathways. These molecular processes enable HLF to contribute to adaptive responses to hypoxia, promoting cell survival and metabolic homeostasis (Ema1999Molecular).

## Clinical Significance
The hepatic leukemia factor (HLF) gene, a member of the PAR bZIP transcription factor family, is implicated in various diseases due to its altered expression and genetic mutations. In cancer, HLF is generally downregulated across multiple tumor types, including bladder urothelial carcinoma, breast cancer, and colorectal cancer, where its decreased expression is associated with poor survival outcomes and advanced clinicopathological stages (Lin2024Pancancer). HLF's role as a potential tumor suppressor is highlighted by its involvement in critical signaling pathways such as calcium signaling and actin cytoskeleton regulation, which are essential for cancer progression and metastasis (Lin2024Pancancer).

In the context of epilepsy, particularly temporal lobe epilepsy, HLF expression is significantly downregulated during epileptogenesis. This downregulation is linked to increased neuronal excitability and seizure activity. Studies using mouse models have shown that the deletion of HLF exacerbates seizures, indicating its crucial role in maintaining normal neuronal function (Rambousek2020Aberrant). The suppression of HLF and other PAR bZIP transcription factors is associated with proinflammatory cytokines, suggesting a complex regulatory mechanism in response to neurotoxic insults (Rambousek2020Aberrant). These findings underscore the importance of HLF in both cancer and neurological disorders.

## Interactions
The HLF (Hepatic Leukemia Factor) transcription factor is known to participate in various interactions with proteins and nucleic acids, playing a significant role in transcriptional regulation. HLF belongs to the bZIP family of transcription factors, which require dimerization for effective DNA binding. It can form heterodimers with other bZIP proteins such as DBP (D-site Binding Protein) and TEF (Thyrotroph Embryonic Factor), enhancing its DNA-binding affinity and specificity. These heterodimers are particularly effective in binding to promoter elements of genes like Factor VIII and Factor IX, leading to increased transcriptional activity (Begbie1999Enhanced).

The E2A-HLF fusion protein, resulting from a chromosomal translocation in certain leukemias, retains the DNA-binding domain of HLF and can bind to a specific 10-bp consensus sequence, 5'-GTTACGTAAT-3'. This fusion protein acts as a potent trans activator of genes containing this sequence, potentially contributing to leukemogenesis by altering transcriptional programs (Hunger1994DNABinding; Inaba1994DNABinding). The E2A-HLF protein can also form heterodimers with other bZIP proteins, although its ability to bind as a homodimer is impaired due to an amino acid substitution in the leucine zipper domain (Inaba1994DNABinding).


## References


[1. (Rambousek2020Aberrant) Lukas Rambousek, Tilo Gschwind, Carlos Lafourcade, Jean-Charles Paterna, Linda Dib, Jean-Marc Fritschy, and Adriano Fontana. Aberrant expression of par bzip transcription factors is associated with epileptogenesis, focus on hepatic leukemia factor. Scientific Reports, February 2020. URL: http://dx.doi.org/10.1038/s41598-020-60638-7, doi:10.1038/s41598-020-60638-7. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-020-60638-7)

[2. (Lin2024Pancancer) Yirong Lin, Zuming Xiong, Yongjun Yang, Wenxin Li, Wei Huang, Minglin Lin, and Sen Zhang. Pan-cancer bioinformatics analysis of hepatic leukemia factor and further validation in colorectal cancer. Translational Cancer Research, 13(7):3299–3317, July 2024. URL: http://dx.doi.org/10.21037/tcr-23-2274, doi:10.21037/tcr-23-2274. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.21037/tcr-23-2274)

[3. (Hunger1996The) SP Hunger, S Li, MZ Fall, L Naumovski, and ML Cleary. The proto-oncogene hlf and the related basic leucine zipper protein tef display highly similar dna-binding and transcriptional regulatory properties. Blood, 87(11):4607–4617, June 1996. URL: http://dx.doi.org/10.1182/blood.v87.11.4607.bloodjournal87114607, doi:10.1182/blood.v87.11.4607.bloodjournal87114607. This article has 29 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood.v87.11.4607.bloodjournal87114607)

[4. (Ema1999Molecular) M. Ema. Molecular mechanisms of transcription activation by hlf and hif1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with cbp/p300. The EMBO Journal, 18(7):1905–1914, April 1999. URL: http://dx.doi.org/10.1093/emboj/18.7.1905, doi:10.1093/emboj/18.7.1905. This article has 446 citations.](https://doi.org/10.1093/emboj/18.7.1905)

[5. (Begbie1999Enhanced) Megan Begbie, Christopher Mueller, and David Lillicrap. Enhanced binding of hlf/dbp heterodimers represents one mechanism of par protein transactivation of the factor viii and factor ix genes. DNA and Cell Biology, 18(2):165–173, February 1999. URL: http://dx.doi.org/10.1089/104454999315556, doi:10.1089/104454999315556. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1089/104454999315556)

[6. (Hunger1994DNABinding) Stephen P. Hunger, Roxane Brown, and Michael L. Cleary. Dna-binding and transcriptional regulatory properties of hepatic leukemia factor (hlf) and the t(17;19) acute lymphoblastic leukemia chimera e2a-hlf. Molecular and Cellular Biology, 14(9):5986–5996, September 1994. URL: http://dx.doi.org/10.1128/mcb.14.9.5986-5996.1994, doi:10.1128/mcb.14.9.5986-5996.1994. This article has 2 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.14.9.5986-5996.1994)

[7. (Hunger1992Hlf) S P Hunger, K Ohyashiki, K Toyama, and M L Cleary. Hlf, a novel hepatic bzip protein, shows altered dna-binding properties following fusion to e2a in t(17;19) acute lymphoblastic leukemia. Genes &amp; Development, 6(9):1608–1620, September 1992. URL: http://dx.doi.org/10.1101/gad.6.9.1608, doi:10.1101/gad.6.9.1608. This article has 179 citations.](https://doi.org/10.1101/gad.6.9.1608)

[8. (Inaba1994DNABinding) Toshiya Inaba, Linda H. Shapiro, Tetsunori Funabiki, Anne E. Sinclair, Bart G. Jones, Richard A. Ashmun, and A. Thomas Look. Dna-binding specificity and trans-activating potential of the leukemia-associated e2a-hepatic leukemia factor fusion protein. Molecular and Cellular Biology, 14(5):3403–3413, May 1994. URL: http://dx.doi.org/10.1128/mcb.14.5.3403-3413.1994, doi:10.1128/mcb.14.5.3403-3413.1994. This article has 5 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.14.5.3403-3413.1994)